Name
Session V: Therapeutic Approaches to Fibrosis
Date & Time
Tuesday, June 9, 2026, 3:30 PM - 5:30 PM
Speakers
Scott Friedman MD, Icahn School of Medicine at Mount Sinai
Carine Boustany, PhD, Boehringer Ingelheim
Mitchell Jones, MD, PhD, Palisade Bio
Scott MacDonnell, PhD, Regeneron
Thomas Wynn, Pfizer
Carine Boustany, PhD, Boehringer Ingelheim
Mitchell Jones, MD, PhD, Palisade Bio
Scott MacDonnell, PhD, Regeneron
Thomas Wynn, Pfizer
Description
Chairperson: Scott MacDonnell, PhD, Regeneron
3:30 PM
Mechanism of Action of Nerandomilast in Pulmonary Fibrosis
Carine Boustany, PhD, Boehringer Ingelheim
3:55 PM
From Mouse to Human: Translational Modeling of Intestinal Fibrosis in IBD
Scott MacDonnell, PhD, Regeneron
4:20 PM
Gut Restricted PED4 Inhibitor for the Treatment of Fibrostenosing Crohn’s Disease
Mitchell Jones, MD, PhD, Palisade Bio
4:45 PM
Closing Keynote Presentation: Fibrosis — From Mechanisms to Medicines
Thomas A Wynn, PhD, Pfizer